Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system (2022)
- Authors:
- USP affiliated authors: DURIGON, EDISON LUIZ - ICB ; WRENGER, CARSTEN - ICB ; ZUCOLOTTO, VALTENCIR - IFSC ; MIRANDA, RENATA RANK - IFSC ; NADDEO, NATÁLIA NORONHA FERREIRA - IFSC ; LINS, PAULA MARIA PINCELA - IFSC ; FERREIRA, LEONARDO MIZIARA BARBOZA - IFSC ; KRÜGER, ARNE - ICB ; CARDOSO, VALÉRIA MARIA DE OLIVEIRA - IFSC ; SOUZA, EDMARCIA ELISA DE - ICB
- Unidades: ICB; IFSC
- DOI: 10.1021/acsabm.2c00349
- Subjects: MICROBIOLOGIA; PARASITOLOGIA; COVID-19; PLANEJAMENTO DE FÁRMACOS; NANOPARTÍCULAS; NANOTECNOLOGIA; ANTIVIRAIS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington, DC
- Date published: 2022
- Source:
- Título do periódico: ACS Applied Bio Materials
- ISSN: 2576-6422
- Volume/Número/Paginação/Ano: v. 5, n. 7, p. 3371-3383, July 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MIRANDA, Renata Rank et al. Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system. ACS Applied Bio Materials, v. 5, n. 7, p. 3371-3383, 2022Tradução . . Disponível em: https://doi.org/10.1021/acsabm.2c00349. Acesso em: 03 jun. 2024. -
APA
Miranda, R. R., Ferreira, N. N., Souza, E. E. de, Lins, P. M. P., Ferreira, L. M. B., Kruger, A., et al. (2022). Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system. ACS Applied Bio Materials, 5( 7), 3371-3383. doi:10.1021/acsabm.2c00349 -
NLM
Miranda RR, Ferreira NN, Souza EE de, Lins PMP, Ferreira LMB, Kruger A, Cardoso VM de O, Durigon EL, Wrenger C, Zucolotto V. Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system [Internet]. ACS Applied Bio Materials. 2022 ; 5( 7): 3371-3383.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1021/acsabm.2c00349 -
Vancouver
Miranda RR, Ferreira NN, Souza EE de, Lins PMP, Ferreira LMB, Kruger A, Cardoso VM de O, Durigon EL, Wrenger C, Zucolotto V. Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system [Internet]. ACS Applied Bio Materials. 2022 ; 5( 7): 3371-3383.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1021/acsabm.2c00349 - Nanostructured delivery systems encapsulating fingolimod for application in Covid-19 therapy
- Stimuli-responsive polymeric nanoparticles as controlled drug delivery systems
- Estudo da formação de corona de mucina em nanopartículas de ouro
- Smart systems in bio-encapsulation for cancer therapy
- Understanding mucus modulation behavior of chitosan oligomers and dextran sulfate combining light scattering and calorimetric observations
- Development and application of nanopharmaceuticals from the repurposing of therapeutic agents against Covid-19: mucus-modulation studies
- Nanoencapsulated Remdesivir as a novel strategy for Covid-19 therapy
- Study of the formation of mucin corona in gold nanoparticles
- Editorial: Emerging human viruses with pandemic potential: Diagnostics, pathogenesis, and therapeutics
- Novel highlight in malarial drug discovery: aspartate transcarbamoylase
Informações sobre o DOI: 10.1021/acsabm.2c00349 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 3083636.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
